Differential diagnosis of Parkinson's disease

Medical Clinics of North America

Volumn 83, Issue 2, 1999, Pages 349-367

  Adler, C H ^a  

^a Department of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BUTYROPHENONE; CARBON DISULFIDE; CARBON MONOXIDE; CHLORPROMAZINE; CISAPRIDE; CYANIDE; CYTARABINE; DIQUAT; FLUNARIZINE; HALOPERIDOL; MANGANESE; METHYLDOPA; METOCLOPRAMIDE; MEVINOLIN; NEUROLEPTIC AGENT; PHENOTHIAZINE; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; RESERPINE; THIOXANTHENE; VERAPAMIL;

ANAMNESIS; AUTOPSY; BRAIN INJURY; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG USE; GENETIC DISORDER; HUMAN; HYDROCEPHALUS; INFECTION; INTOXICATION; METABOLIC DISORDER; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PARKINSONISM; PATHOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0033029904     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70108-5     Document Type: Article

References (116)

1. R.D. Adams C.M. Fisher S. Hakim Symptomatic occult hydrocephalus with “normal” cerebrospinal fluid pressure (a treatable syndrome) N Engl J Med 273 1965 117 126
2. C.H. Adler M.B. Stern M.L. Brooks Parkinsonism secondary to bilateral striatal fungal abscesses Mov Disord 4 1989 333 337
3. L. Ahtee G. Buncombe Metoclopramide induces catalepsy and increases striatal homovanillic acid content in mice Acta Pharmacol Toxicol 35 1974 429 432
4. A. Albanese C. Colosimo A.R. Bentivoglio Multiple system atrophy presenting as parkinsonism: Clinical features and diagnostic criteria J Neurol Neurosurg Psychiatry 59 1995 144 151
5. E. Beck P.M. Daniel Neuropathology of transmissible spongiform encephalopathies Pruisner S.B. McKinley M.P. Prions: Novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease 1987 Academic Press San Diego 331 383
6. J.R. Berger D.B. Ross Reversible Parkinson syndrome complicating post-operative hypoparathyroidism Neurology 31 1981 881 882
7. J. Blin M.J. Vidailhet B. Pillon Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PET Mov Disord 7 1992 348 354
8. V. Bocola G. Fabbrini A. Sollecito Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs J Neurol Neurosurg Psychiatry 60 1996 213 216
9. P. Bolcq G. Marinesco Sur un cas tremblement parkinsonien hemiplegique symptomatique d'une tumeur de pedoncule cerebral CR Soc Biol (Paris) 45 1893 111 105
10. G.J. Brewer V. Johnson R.D. Dick Treatment of Wilson disease with ammonium tetrathiomolybdate Arch Neurol 53 1996 1017 1025
11. D.J. Brooks Neuroimaging of movement disorders Watts R.L. Koller W.C. Movement Disorders: Neurologic Principles and Practice 1997 McGraw-Hill New York 31 48
12. A.S. Buchman C.G. Goetz H.L. Klawans Hemiparkinsonism with hemiatrophy Neurology 38 1988 527 530
13. C. Burkhardt J.P. Kelley Y.H. Lim Neuroleptic medications inhibit complex I of the electron transport chain Ann Neurol 33 1993 512 517
14. K.L. Busenbark S.J. Huber G. Greer Olfactory function in essential tremor Neurology 42 1992 1631 1632
15. D.B. Calne N.S. Chu C.C. Huang Manganism and idiopathic parkinsonism: Similarities and differences Neurology 44 1994 1583 1586
16. J.Y. Chen Y. Stern M. Sano Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease Arch Neurol 48 1991 1141 1143
17. D.G. Cook S. Fahn K.A. Brait Chronic manganese intoxication Arch Neurol 30 1974 59 64
18. C.B. Courville Effects of closed cranial injuries on the midbrain and upper pons Res Publ Assoc Res Nerv Ment Dis 24 1945 131 150
19. T. Curran A.E. Lang Parkinsonian syndromes associated with hydrocephalus: Case reports, a review of the literature, and pathophysiological hypotheses Mov Disord 9 1994 508 520
20. S.E. Daniel A.J. Lees Parkinson's Disease Society Brain Bank, London: Overview and research J Neural Transm 39 suppl 1993 165 172
21. M. Demirkiran J. Jankovic R.A. Lewis Neurologic presentation of Wilson disease without Kayser-Fleischer rings Neurology 46 1996 1040 1043
22. A. Durr G. Stevanin G. Cancel Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features Ann Neurol 39 1996 490 499
23. R.C. Duvoisin M.D. Yahr Encephalitis and parkinsonism Arch Neurol 12 1965 227 239
24. D. Eidelberg V. Dhawan J.R. Moeller The metabolic landscape of cortico-basal ganglionic degeneration: Regional asymmetries studied with positron emission tomography J Neurol Neurosurg Psychiatry 54 1991 856 862
25. 18F-fluorodeoxyglucose and positron emission tomography Neurology 45 1995 1995 2004
26. S.A. Factor Posttraumatic parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 95 110
27. S.A. Factor W.J. Weiner Prior history of head trauma in Parkinson's disease Mov Disord 6 1991 225 229
28. M.B. Feany L.A. Mattiace D.W. Dickson Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration J Neuropathol Exp Neurol 55 1996 53 67
29. G. Fenelon J.L. Houteto Unilateral parkinsonism following a large infarct in the territory of the lenticulostriate arteries Mov Disord 12 1997 1086 1090
30. J.H. Friedman Postencephalitic parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 203 226
31. D. Galasko R. Katzman D.P. Salmon Clinical and neuropathological findings in Lewy body dementias Brain Cogn 31 1996 166 175
32. Garcia de Yebenes J. J.J. Gervas J. Iglesias Biochemical findings in a case of parkinsonism secondary to brain tumor Ann Neurol 11 1981 313 316
33. R. Gherardi B. Rouldes J. Fleury Parkinsonian syndrome and central nervous system lymphoma involving the substantia nigra Acta Neuropathol 65 1985 338 343
34. N. Giladi R.E. Burke V. Kostic Hemiparkinsonism-hemiatrophy syndrome: Clinical and neuroradiologic features Neurology 40 1990 1731 1734
35. S. Gilman R.A. Koeppe L. Junck Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy Ann Neurol 36 1994 166 175
36. E.S. Goldensohn J. Hardie E.D. Borea Ethosuximide in the treatment of epilepsy JAMA 180 1962 840 842
37. S.M. Gollomp Rigid variant of Huntington's disease Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 313 320
38. M. Grisoli V. Fetoni M. Savoiardo MRI in corticobasal degeneration Eur J Neurol 2 1995 547 552
39. M. Gross Giant middle cerebral artery aneurysm presenting as hemiparkinsonism J Neurol Neurosurg Psychiatry 50 1987 1075
40. A.M. Hakim G. Mathieson Dementia in Parkinson's disease: A neuropathologic study Neurology 29 1979 1209 1214
41. R.S. Hauser Neuroleptic induced parkinsonism and Parkinson's disease: Differential diagnosis and treatment J Clin Psychiatry 44 1983 13 16
42. J.J. Hauw S.E. Daniel D. Dickson Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy) Neurology 44 1994 2015 2019
43. J.J. Higgins L.E. Nee O. Vasconcelos Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease Neurology 46 1996 208 213
44. J.P. Hubble Drug-induced parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 111 122
45. A.J. Hughes S.E. Daniel S. Blankson A clinicopathologic study of 100 cases of Parkinson's disease Arch Neurol 50 1993 140 148
46. H.I. Hurtig Vascular parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 81 93
47. T. Ikeuchi R. Koide H. Tanaka Dentatorubral-pallidoluysian atrophy: Clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat Ann Neurol 37 1995 769 775
48. T. Indo K. Ando Metoclopramide-induced parkinsonism Arch Neurol 39 1982 494 496
49. L. Jacobs D. Conti W.R. Kinkel “Normal-pressure” hydrocephalus: Relationship of clinical and radiographic findings to improvement following shunt surgery JAMA 235 1976 510 512
50. J. Jankovic Post-traumatic movement disorders: Central and peripheral mechanisms Neurology 44 1994 2006 2014
51. J. Jankovic Tardive syndromes and other drug-induced movement disorders Clin Neuropharmacol 18 1995 197 214
52. J.R. Keane Tremor as the result of shunt obstruction: Four patients with cysticercosis and secondary parkinsonism: Report of four cases Neurosurgery 37 1995 520 522
53. H.L. Klawans R.W. Stein C.M. Tanner A pure parkinsonism syndrome following acute carbon monoxide poisoning Arch Neurol 39 1982 302 304
54. R. Koide T. Ideuchi O. Onodera Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) Nat Genet 6 1994 9 13
55. W.C. Koller A.E. Lang Psychogenic parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 503 507
56. W.C. Koller G.F. Wong A. Lang Posttraumatic movement disorders: A review Mov Disord 4 1989 20 36
57. I.J. Kopin Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals Adv Neurol 45 1986 137 144
58. J.K. Krauss J.P. Regel D.W. Droste Movement disorders in adult hydrocephalus Mov Disord 12 1997 53 60
59. J.W. Langston P. Ballard J.W. Tetrud Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
60. I. Litvan Y. Agid D. Calne Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop Neurology 47 1994 1 9
61. I. Litvan Y. Agid C. Goetz Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study Neurology 48 1997 119 125
62. I. Litvan C.G. Goetz J. Jankovic What is the accuracy of the clinical diagnosis of multiple system atrophy? Arch Neurol 54 1997 937 944
63. O.L. Lopez S.R. Wisnieski J.T. Becker Extrapyramidal signs in patients with probable Alzheimer disease Arch Neurol 54 1997 969 975
64. J.S. Lou J. Jankovic Essential tremor: Clinical correlates in 350 patients Neurology 41 1991 234 238
65. E.D. Louis L.A. Klatka Y. Liu Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease Neurology 48 1997 376 380
66. P.A. Low J.L. Allsop G.M. Halmagyi Huntington's chorea: The rigid form (Westphal variant) treated with levodopa Med J Aust 1 1974 393 394
67. C.S. Lu C.C. Huang N.S. Chu Levodopa failure in chronic manganism Neurology 44 1994 1600 1602
68. F.A. Luque J.B. Selhorst P. Petruska Parkinsonism induced by high-dose cytosine arabanoside Mov Disord 2 1987 219 222
69. I.G. McKeith D. Galasko K. Kosaka Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
70. M.S. Mega D.L. Masterman D.F. Benson Dementia with Lewy bodies: Reliability and validity of clinical and pathologic criteria Neurology 47 1996 1403 1409
71. L.G. Miller J. Jankovic Metoclopramide-induced movement disorders Arch Intern Med 149 1989 2486 2492
72. P.K. Molsa R.J. Marttila U.K. Rinne Extrapyramidal signs in Alzheimer's disease Neurology 34 1984 1114 1116
73. J.C. Morris M. Drazner K. Fulling Clinical and pathological aspects of parkinsonism in Alzheimer's disease: A role for extranigral factors Arch Neurol 46 1989 651 657
74. T. Muller W. Kuhn D. Pohlau Parkinsonism unmasked by lovastatin Ann Neurol 37 1995 685 686
75. R.W. Murrow G.D. Schweiger J.J. Kepes Parkinsonism due to a basal ganglia lacunar state: Clinicopathologic correlation Neurology 40 1990 897 900
76. R. Musella A.R. Elvidge Parkinsonian-like syndrome caused by cyst in posterior fossa J Neurosurg 21 1964 62 65
77. S. Nagafuchi H. Yanagisawa K. Sato Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p Nat Genet 6 1994 14 18
78. J.E. Nielsen S.A. Sorensen L. Hasholt Dentatorubral-pallidoluysian atrophy: Clinical features of a five-generation Danish family Mov Disord 11 1996 533 541
79. R. Pahwa W.C. Koller Is there a relationship between Parkinson's disease and essential tremor? Clin Neuropharmacol 16 1993 30 35
80. B.M. Patten Wilson's disease Jankovic J. Tolosa E. Parkinson's Disease and Movement Disorders, ed 2 1993 Williams & Wilkins Baltimore 217 233
81. G.W. Paulson A. Aotsuka Parkinsonian syndromes Semin Neurol 13 1993 359 364
82. D. Perani S. Bressi D. Testa Clinical/metabolic correlations in multiple system atrophy Arch Neurol 52 1995 179 185
83. G. Pezzoli S. Barbieri C. Ferrante Parkinsonism due to n-hexane exposure Lancet 2 1989 874
84. R.F. Pfeiffer M. Ebadi Wilsons's disease Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 321 340
85. K.S. Polyzoidis J.D. McQueen A.H. Rajput Parkinsonism as a manifestation of brain tumor Surg Neurol 23 1985 59 63
86. D. Rail C. Scholtz M. Swash Post-encephalitic parkinsonism: Current experience J Neurol Neurosurg Psychiatry 44 1981 670 676
87. A.H. Rajput K.P. Offord C.M. Beard Essential tremor in Rochester, Minnesota: A 45-year study J Neurol Neurosurg Psychiatry 47 1984 466 470
88. A.H. Rajput B. Rozdilsky A. Rajput Significance of parkinsonian manifestations in essential tremor Can J Neurol Sci 20 1993 114 117
89. R.T. Ravenholt W.H. Foege 1918 influenza, encephalitis lethargica, parkinsonism Lancet 2 1982 860 864
90. D.E. Riley A.E. Lang Cortical-basal ganglionic degeneration Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 379 392
91. D.E. Riley A.E. Lang A. Lewis Cortical-basal ganglionic degeneration Neurology 40 1990 1203 1212
92. R. Roos D.C. Gajdusek C.J. Gibbs The clinical characteristics of transmissible Creutzfeldt-Jakob disease Brain 96 1973 1 20
93. N.L. Rosenberg J.A. Myers W.R. Martin Cyanide-induced parkinsonism: Clinical, MRI, and 6-fluorodopa PET studies Neurology 39 1989 142 144
94. R.T. Ross Drug-induced parkinsonism and other movement disorders Can J Neurol Sci 17 1990 155 162
95. J.I. Sage M.H. Mark Diffuse Lewy body disease Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 393 411
96. J.R. Sanchez-Ramos Toxin-induced parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 155 193
97. R. Sandyk I. Kahn Parkinsonism due to subdural hematoma J Neurosurg 58 1983 298 299
98. J.A. Schneider R.L. Watts M. Gearing Corticobasal degeneration: Neuropathologic and clinical heterogeneity Neurology 48 1997 959 969
99. G.P. Sechi V. Agnetti M. Piredda Acute and persistent parkinsonism after use of diquat Neurology 42 1992 261 263
100. K.M. Shannon Hydrocephalus and parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 123 136
101. M. Stern E. Dulaney S.B. Gruber The epidemiology of Parkinson's disease: A case-control study of young-onset and old-onset patients Arch Neurol 48 1991 903 907
102. P.J. Sweeney Metabolic causes of parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 195 200
103. C.M. Tanner Occupational and environmental causes of parkinsonism Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 145 154
104. J.W. Tetrud J.W. Langston MPTP and Parkinson's disease: One decade later Stern M.B. Koller W.C. Parkinsonian Syndromes 1993 Marcel Dekker New York 173 193
105. G.R. Thomas J.R. Forbes E.A. Roberts The Wilson disease gene: Spectrum of mutations and their consequences Nat Genet 9 1995 210 217
106. R. Tinker M.G. Anderson P. Anananand Pontine myelinolysis presenting with acute parkinsonism as a sequel of corrected hyponatremia J Neurol Neurosurg Psychiatry 53 1990 87
107. E.S. Tolosa J. Santamaria Parkinsonism and basal ganglia infarcts Neurology 134 1984 1516 1518
108. 18F]Dopa positron-emission tomography study Mov Disord 12 1997 1035 1038
109. R.J. Uitti A.H. Rajput E.M. Asenhurst Cyanide induced parkinsonism: A clinico-pathologic report Neurology 35 1985 921 925
110. R.J. Uitti B.J. Snow H. Shinotoh Parkinsonism induced by solvent abuse Ann Neurol 35 1994 616 619
111. J. Vanneste P. Augustijn C. Dirven Shunting normal-pressure hydrocephalus: Do the benefits outweigh the risks? A multicenter study and literature review Neurology 42 1992 54 59
112. van Zagten M. J. Lodder F. Kessels Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions Mov Disord 13 1998 89 95
113. T.T. Warner L.D. Williams R.W.H. Walker A clinical and molecular genetic study of dentatorubropallidoluysian atrophy in four European families Ann Neurol 37 1995 452 459
114. W.J. Weiner A.E. Lang Movement Disorders: A Comprehensive Survey 1989 Futura Mount Kisco, NY
115. E.G. Werner C.W. Olanow Parkinsonism and amiodarone therapy Ann Neurol 25 1989 630 632
116. D.W. Zochodone G.B. Young R.S. McLachlan Creutzfeldt-Jakob disease without periodic sharp wave complexes Neurology 38 1988 1056 1060